P548: BEMCENTINIB COMBINED WITH LOW-DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II TRIAL (NCT02488408)

• S. Loges,
• M. Heuser,
• J. Chromik,
• G. Sutamtewagul,
• S. Kapp-Schwoerer,
• M. Crugnola,
• N. Di Renzo,
• R. Lemoli,
• D. Mattei,
• I. Ben-Batalla,
• J. Waizenegger,
• L.-M. Rieckmann,
• M. Janning,
• C. D. Imbusch,
• N. Beumer,
• D. Micklem,
• C. Gorcea-Carson,
• G. Lawson,
• J. Nautiyal,
• S. Deharo,
• W. Fiedler,
• Y. Alvarado-Valero,
• B. Gjertsen

Affiliations

S. Loges

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

M. Heuser

4 Hematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover

J. Chromik

5 University Hospital Frankfurt, Frankfurt, Germany

G. Sutamtewagul

6 University of Iowa Hospitals and Clinics, Iowa City, United States of America

S. Kapp-Schwoerer

7 University Hospital of Ulm, Ulm, Germany

M. Crugnola

8 University of Parma, Parma

N. Di Renzo

9 Haematology and SCT Unit, Vito Fazzi Hospital, Lecce

R. Lemoli

10 University of Genoa, Genoa

D. Mattei

11 ASOS. Croce e Carle, Cuneo, Italy

I. Ben-Batalla

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

J. Waizenegger

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

L.-M. Rieckmann

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

M. Janning

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

C. D. Imbusch

2 Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg

N. Beumer

1 DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim

D. Micklem

13 BerGenBio ASA, Bergen, Norway

C. Gorcea-Carson

14 BerGenBio Ltd, Oxford, United Kingdom

G. Lawson

14 BerGenBio Ltd, Oxford, United Kingdom

J. Nautiyal

14 BerGenBio Ltd, Oxford, United Kingdom

S. Deharo

14 BerGenBio Ltd, Oxford, United Kingdom

W. Fiedler

15 University Medical Center Hamburg, Hamburg, Germany

Y. Alvarado-Valero

16 The University of Texas M.D. Anderson Cancer Center, Houston, United States of America

B. Gjertsen

17 Haukeland University Hospital, Bergen, Norway